Bharat [BIBCL] vs Biocon [BIOCON] Detailed Stock Comparison

Bharat Immunologicals & Biologicals Corporation Limited

BSE
Loading...

Biocon Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bharat Immunologicals & Biologicals Corporation Limited wins in 1 metrics, Biocon Ltd. wins in 16 metrics, with 0 ties. Biocon Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bharat Immunologicals & Biologicals Corporation Limited Biocon Ltd. Better
P/E Ratio (TTM) -4.59 71.84 Biocon Ltd.
Price-to-Book Ratio 0.97 1.68 Bharat Immunologicals & Biologicals Corporation Limited
Debt-to-Equity Ratio 94.48 50.02 Biocon Ltd.
PEG Ratio -0.08 0.17 Biocon Ltd.
EV/EBITDA -7.13 19.22 Biocon Ltd.
Profit Margin (TTM) -241.59% 3.59% Biocon Ltd.
Operating Margin (TTM) -2,888.44% 7.63% Biocon Ltd.
EBITDA Margin (TTM) N/A 7.63% N/A
Return on Equity -21.00% 3.66% Biocon Ltd.
Return on Assets (TTM) -6.28% 1.72% Biocon Ltd.
Free Cash Flow (TTM) $108.92M $17.18B Biocon Ltd.
Dividend Yield N/A 0.26% N/A
1-Year Return -32.86% 17.90% Biocon Ltd.
Price-to-Sales Ratio (TTM) 9.97 3.37 Biocon Ltd.
Enterprise Value $1.42B $643.51B Biocon Ltd.
EV/Revenue Ratio 18.52 3.82 Biocon Ltd.
Gross Profit Margin (TTM) N/A 67.91% N/A
Revenue per Share (TTM) $2 $133 Biocon Ltd.
Earnings per Share (Diluted) $-3.59 $4.87 Biocon Ltd.
Beta (Stock Volatility) 0.34 0.25 Biocon Ltd.

Bharat Immunologicals & Biologicals Corporation Limited vs Biocon Ltd. Stock Performance Analysis

Loading Price Chart...

BIBCL
BIOCON

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bharat Immunologicals & Biologicals Corporation Limited0.71%-1.61%-1.38%5.28%-9.50%-14.68%
Biocon Ltd.-0.70%1.66%-3.27%10.34%6.50%7.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bharat Immunologicals & Biologicals Corporation Limited-32.86%-26.70%-80.09%-12.27%29.14%57.16%
Biocon Ltd.17.90%71.09%5.03%250.57%603.49%1,357.39%

Performance & Financial Health Analysis: Bharat Immunologicals & Biologicals Corporation Limited vs Biocon Ltd.

MetricBIBCLBIOCON
Market Information
Market Cap i₹762.99M₹566.52B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i35,1002,496,867
90 Day Avg. Volume i35,5153,790,310
Last Close₹17.14₹416.05
52 Week Range₹14.10 - ₹25.65₹331.00 - ₹440.40
% from 52W High-33.18%-5.53%
All-Time High₹94.50 (Jun 14, 2021)₹487.75 (Dec 21, 2020)
% from All-Time High-81.86%-14.70%
Growth Metrics
Quarterly Revenue Growth-0.99%0.09%
Quarterly Earnings Growth-1.00%4.73%
Financial Health
Profit Margin (TTM) i-2.42%0.04%
Operating Margin (TTM) i-28.88%0.08%
Return on Equity (TTM) i-0.21%0.04%
Debt to Equity (MRQ) i94.4850.02
Cash & Liquidity
Book Value per Share (MRQ)₹18.24₹207.92
Cash per Share (MRQ)₹2.07₹45.84
Operating Cash Flow (TTM) i₹87.48M₹17.78B
Levered Free Cash Flow (TTM) i₹-166,388,000₹10.13B
Dividends
Last 12-Month Dividend Yield iN/A0.26%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: Bharat Immunologicals & Biologicals Corporation Limited vs Biocon Ltd.

MetricBIBCL (Apr 26, 2026)BIOCON (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-4.5971.84
Forward P/E iN/A38.56
PEG Ratio i-0.080.17
Price to Sales (TTM) i9.973.37
Price to Book (MRQ) i0.971.68
Market Capitalization
Market Capitalization i₹762.99M₹566.52B
Enterprise Value i₹1.42B₹643.51B
Enterprise Value Metrics
Enterprise to Revenue i18.523.82
Enterprise to EBITDA i-7.1319.22
Risk & Other Metrics
Beta i0.340.25
Book Value per Share (MRQ) i₹18.24₹207.92

Financial Statements Comparison: Bharat Immunologicals & Biologicals Corporation Limited vs Biocon Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBIBCL (2023)BIOCON (2025)
Revenue/Sales i446.09M150.52B
Cost of Goods Sold i422.08M51.98B
COGS % of Revenue i94.6%34.5%
Gross Profit i24.01M98.54B
Gross Margin i5.4%65.5%
Research & Development i06.34B
Operating Income (EBIT) i-160.07M16.26B
Operating Margin i-35.9%10.8%
EBITDA i-154.93M33.60B
EBITDA Margin i-34.7%22.3%
Pre-Tax Income i-222.68M18.87B
Pre-Tax Income % of Revenue i-49.9%12.5%
Income Tax i-56.29M4.57B
Income Tax % of Revenue i-12.6%3.0%
Net Income (Profit) i-166.39M14.29B
Profit Margin i-37.3%9.5%

Balance Sheet & Liquidity Metrics

MetricBIBCL (2023)BIOCON (2025)
Cash & Equivalents i12.86M32.27B
Total Current Assets i358.03M162.86B
Total Current Assets % of Revenue i80.3%108.2%
Total Current Liabilities i940.42M143.34B
Total Current Liabilities % of Revenue i210.8%95.2%
Long-Term Debt iN/A129.45B
Long-Term Debt % of Revenue i0.0%86.0%
Total Shareholders Equity i882.14M277.13B
Retained Earnings i-662.11M189.59B
Retained Earnings % of Revenue i-148.4%126.0%
Property, Plant & Equipment i72.02M4.32B

Cash Flow Statement Comparison

MetricBIBCL (2023)BIOCON (2025)
Operating Cash Flow i87.48M17.78B
Operating Cash Flow % of Revenue i19.6%11.8%
Capital Expenditures i0-21.36B
Free Cash Flow i108.92M17.18B
FCF Margin i24.4%11.4%
Debt Repayment iN/A-97.70B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBIBCLBIOCON
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i43.18M1.62B
Float Shares i17.58M583.07M
% Held by Insiders i59.25%54.07%
% Held by Institutions i0.00%24.88%
% Held by Public i40.75%21.05%

Dividend Analysis & Yield Comparison: Bharat Immunologicals & Biologicals Corporation Limited vs Biocon Ltd.

MetricBIBCLBIOCON
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.26%
3-Year Avg Annual Dividend iN/A₹1.33
3-Year Avg Dividend Yield iN/A0.36%
3-Year Total Dividends iN/A₹4.00
Ex-Dividend DateN/AJul 04, 2025